Welcome to our dedicated page for Creatd news (Ticker: CRTDD), a resource for investors and traders seeking the latest updates and insights on Creatd stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Creatd's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Creatd's position in the market.
Creatd (OTCQB: CRTD) set the record date for its annual shareholder meeting on April 17, 2026, with a virtual meeting scheduled for May 21, 2026. Shareholders of record at the close of business on April 17 may vote electronically.
The company said it is preparing to file 2025 audited financials and to re-register with the SEC as part of steps toward uplisting after trading above $4.00 for 30 consecutive days. The company previously traded under the temporary symbol CRTDD following a reverse split and has returned to CRTD.
Creatd (OTCQB: CRTDD) sold its remaining 80% stake in Fly Flyte to NYSE American-listed Catheter Precision (VTAK) on March 10, 2026, receiving about $6,000,000 cash plus nearly $6,000,000 in VTAK convertible preferred stock. The transaction strengthens Creatd's balance sheet and leaves Creatd as a significant VTAK shareholder while supporting its national exchange listing strategy and continued collaboration on aviation and eVTOL initiatives.